OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALSOG56

Sogeclair SA

Aerospace & DefenseVerified

Sogeclair's capital structure is characterized by a lack of dilution risk, as shares outstanding remain unchanged between basic and diluted shares at 3,055,508. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the valuation snapshot, and no industry_config preferred metrics are provided for comparison. Analyst estimates indicate a last actual EPS of 1.01 EUR and revenue of 148 million EUR, but these figures do not allow for a direct comparison to cohort medians. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory is not quantified in the outlook, as no numeric deltas or forward-looking revenue guidance is provided. Analyst estimates for the most recent period show a revenue of 148 million EUR, but no projections for the current or next fiscal year are available. Risk factors include an inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as no dilution potential is reported and shares outstanding remain unchanged. Recent events and filings are not detailed in the available source documents, and no transcripts or material disclosures are provided to inform recent company developments.

30-day price · ALSOG+4.10 (+12.8%)
Low$30.50High$42.00Close$36.20As of13 May, 00:00 UTC
Profile
CompanySogeclair SA
TickerALSOG.PA
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Sogeclair SA is an aerospace and defense company that provides specialized engineering and manufacturing services to the aviation and defense sectors.

Classification. Sogeclair is classified under the Aerospace & Defense industry within the Industrial Goods business sector, with a confidence level of 0.92.

Sogeclair's capital structure is characterized by a lack of dilution risk, as shares outstanding remain unchanged between basic and diluted shares at 3,055,508. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the valuation snapshot, and no industry_config preferred metrics are provided for comparison. Analyst estimates indicate a last actual EPS of 1.01 EUR and revenue of 148 million EUR, but these figures do not allow for a direct comparison to cohort medians. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory is not quantified in the outlook, as no numeric deltas or forward-looking revenue guidance is provided. Analyst estimates for the most recent period show a revenue of 148 million EUR, but no projections for the current or next fiscal year are available. Risk factors include an inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as no dilution potential is reported and shares outstanding remain unchanged. Recent events and filings are not detailed in the available source documents, and no transcripts or material disclosures are provided to inform recent company developments.
Key takeaways
  • Sogeclair operates in the aerospace and defense industry with a focus on specialized engineering and manufacturing services.
  • The company shows no dilution risk, with basic and diluted shares outstanding remaining equal at 3,055,508.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Analyst estimates show a last actual EPS of 1.01 EUR and revenue of 148 million EUR, but no forward-looking guidance is available.
  • No segment or geographic exposure data is disclosed, limiting the ability to assess revenue concentration or diversification.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$121.0M$4.1M$2.6M$5.4M
FY-3$134.9M$4.7M$2.0M$2.2M
FY-2$148.0M$6.9M$3.1M$8.8M
FY-1$157.0M$7.1M$4.4M$9.9M
FY0$160.3M$10.2M$5.7M$10.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$150.4M$48.7M$6.4M
FY-3$146.3M$48.3M$6.4M
FY-2$158.6M$48.5M$7.7M
FY-1$152.7M$49.0M$5.7M
FY0$148.3M$51.5M$6.3M
PeriodOCFCapExFCFSBC
FY-4$2.1M-$4.5M$5.4M
FY-3$3.2M-$5.3M$2.2M
FY-2$5.6M-$1.7M$8.8M
FY-1$17.0M-$1.7M$9.9M
FY0$18.8M-$2.2M$10.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$36.7M
FQ-5
FQ-4$41.5M
FQ-3
FQ-2$36.8M
FQ-1
FQ0$39.6M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Aerospace & Defense · cohort 184 companies
MetricALSOGActivity
Op margin6.6% medp25 -6.7% · p75 13.4%
Net margin4.7% medp25 -6.0% · p75 11.0%
Gross margin28.0% medp25 16.8% · p75 46.8%
R&D / revenue4.1% medp25 4.1% · p75 4.1%
CapEx / revenue-6.7% medp25 -17.5% · p75 -3.2%
Debt / equity16.5% medp25 3.2% · p75 44.9%
Observations
IR observations
Last actual EPS1.01 EUR
Last actual revenue148,000,000 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:54 UTC#300e58f6
Market quoteclose EUR 36.20 · shares 0.00B diluted
no public URL
2026-05-13 00:54 UTC#27cddead
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:22 UTCJob: 386ca12c